Method for predicting renal cell carcinoma

Ian Overton; Grant Stewart; Alexander Lubbock; David Harrison; Thomas Powles

Method for predicting renal cell carcinoma

Ian Overton (Inventor)
, Grant Stewart (Inventor)
, Alexander Lubbock (Inventor)
, David Harrison (Inventor)
, Thomas Powles (Inventor)

School of Medicine, Dentistry and Biomedical Sciences

Research output: Patent

Original language	English
Patent number	WO2015170105A1
IPC	G01N33/57438 Specifically defined cancers of liver, pancreas or kidney,C12Q1/6886 Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer,C12Q2600/118 Prognosis of disease development,C12Q2600/158 Expression markers,G01N2333/705 Assays involving receptors, cell surface antigens or cell surface determinants,G01N2800/52 Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Filing date	07/05/2015
Publication status	Published - 12 Nov 2015

Bibliographical note

PCT/GB2015/051345; G01N 33/574 (2006.01)

Access to Document

https://patents.google.com/patent/WO2015170105A1/enLicence: Unspecified

1 Article

Overcoming Intratumoural Heterogeneity for Reproducible Molecular Risk Stratification: A Case Study in Advanced Kidney Cancer
Lubbock, A., Stewart, G., O'Mahony, F. C., Laird, A., Mullen, P., O'Donnell, M., Powles, T., Harrison, D. J. & Overton, I., 26 Jun 2017, In: BMC Medicine. 15, 118.
Research output: Contribution to journal › Article › peer-review

Open Access
File
6 Citations (Scopus)

257 Downloads (Pure)

Cite this

@misc{cca31dbddcdf4233b8393047700f5633,

title = "Method for predicting renal cell carcinoma",

author = "Ian Overton and Grant Stewart and Alexander Lubbock and David Harrison and Thomas Powles",

note = "PCT/GB2015/051345; G01N 33/574 (2006.01); WO2015170105A1; G01N33/57438 Specifically defined cancers of liver, pancreas or kidney,C12Q1/6886 Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer,C12Q2600/118 Prognosis of disease development,C12Q2600/158 Expression markers,G01N2333/705 Assays involving receptors, cell surface antigens or cell surface determinants,G01N2800/52 Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis",

year = "2015",

month = nov,

day = "12",

language = "English",

publisher = "World Intellectual Property Organization (WIPO)",

type = "Patent",

}

Method for predicting renal cell carcinoma

Bibliographical note

Access to Document

Research output

Overcoming Intratumoural Heterogeneity for Reproducible Molecular Risk Stratification: A Case Study in Advanced Kidney Cancer

Cite this